Embryonic stem cells go from bench to bedside for Parkinson’s disease

Clare L. Parish; Lachlan H. Thompson

Cell Reports Medicine (Apr 2021)

Embryonic stem cells go from bench to bedside for Parkinson’s disease

Clare L. Parish,
Lachlan H. Thompson

Affiliations

Clare L. Parish: The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; Corresponding author
Lachlan H. Thompson: The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia

Journal volume & issue: Vol. 2, no. 4
p. 100251

Abstract

Read online

Stem-cell-derived transplants may soon be a promising treatment option for Parkinson’s disease. In preparation for clinical trial, Piao et al.1 report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.

Published in Cell Reports Medicine

ISSN: 2666-3791 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Medicine (General)
Website: https://www.cell.com/cell-reports-medicine

About the journal